U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 14-20, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 14-20, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 07/16/2024
Location: Durham, NC
Subject: Duke Cardiology Grand Rounds: The Cardiovascular Specialist in a Time of Decline in American Cardiometabolic Health
FDA Participant/Group: N/A
Non FDA Participant/Group: Several faculty and trainees from Duke University

Event Date: 07/17/2024
Location: Durham, NC
Subject: Annual Jerry G. Reves Duke Heart Center Lectureship: What Should a Heart and Vascular Center Do in the Next Decade?
FDA Participant/Group: N/A
Non FDA Participant/Group: Several faculty and trainees from Duke University

Event Date: 07/17/2024
Location: Virtual
Subject: CVM Public Meeting: First Annual Animal Drug User Fee Educational Conference
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media, academia, and other registered attendees

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 07/15/2024
Location: Long Beach, CA
Subject: International Association for Food Protection Annual Meeting; Speaker: Regulatory Update on Food Safety
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, academia, and governmental food safety professionals

Event Date: 07/16/2024
Location: Chicago, IL
Subject: Institute of Food Technologists First Annual Event and Expo; Speaker: The Future of FDA's Food Program
FDA Participant/Group: N/A
Non FDA Participant/Group: Researchers, scientists, engineers, and entrepreneurs

Event Date: 07/17/2024
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: U.S. Apple Association Board of Directors

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 07/17/2024
Location: Virtual
Subject: African Pharmaceutical Manufacturing Landscape
FDA Participant/Group: RAVI BHARWANI, JOHN WEINER
Non FDA Participant/Group: Members of U.S. Pharmacopeia

Event Date: 07/17/2024
Location: Virtual
Subject: Life-Saving Medicines in Low- and Middle-Income Countries
FDA Participant/Group: DOUG SHAFFER, BETSY NEWCOMER
Non FDA Participant/Group: Abigail Tan (Access to Medicine);

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 07/15/2024
Location: Silver Spring, MD
Subject: Alliance for a Stronger FDA Meeting; CDER Updates
FDA Participant/Group: VONNEFREEDA JOHNSON;
Non FDA Participant/Group: Industry, regulatory, and other stakeholders

Event Date: 07/16/2024
Location: Washington, DC
Subject: Friedreich’s Ataxia Research Alliance, Pediatric Inclusion Roundtable: Effective Inclusion of Children Early in Clinical Trials; Panelist: FDA Leadership Discussion
FDA Participant/Group: MICHELLE TARVER; PETER MARKS;
Non FDA Participant/Group: Industry, regulatory, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/17/2024
Location: Washington, DC
Subject: NIH Oxford-Cambridge Colloquium Gala; Closing Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the NIH Oxford-Cambridge Colloquium Gala

Event Date: 07/17/2024
Location: Virtual
Subject: Brigham and Women's Hospital Science in Residency Pathway Meeting; Regulatory Efforts to Advance the Development of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Brigham and Women's Hospital Science in Residency Pathway Meeting

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/16/2024
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: MICHAEL HOFFMANN; ANGELA KRUEGER; MICHELLE TARVER; DOUGLAS KELLY;
Non FDA Participant/Group: Yarmela Pavlovic, Geoff Martha, Laura Mauri (Medtronic)

Event Date: 07/16/2024
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: ROBERT OCHS; JESSICA PAULSEN; TROY TAZBAZ; MICHELLE TARVER; OWEN FARIS;
Non FDA Participant/Group: Holger Schmidt, Eva Marie Reiter, Lars Becker, Robert Phillips, Christian Denger, Michael Schaaf (Siemens)

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top